412 related articles for article (PubMed ID: 32381472)
1. Contralateral limb improvement after unilateral iliac vein stenting argues against simultaneous bilateral stenting.
Jayaraj A; Noel C; Raju S
J Vasc Surg Venous Lymphat Disord; 2020 Jul; 8(4):565-571. PubMed ID: 32381472
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcomes following use of a composite Wallstent-Z stent approach to iliofemoral venous stenting.
Jayaraj A; Noel C; Kuykendall R; Raju S
J Vasc Surg Venous Lymphat Disord; 2021 Mar; 9(2):393-400.e2. PubMed ID: 32827734
[TBL] [Abstract][Full Text] [Related]
3. Comparison between a dedicated venous stent and standard composite Wallstent-Z stent approach to iliofemoral venous stenting: Intermediate-term outcomes.
Powell T; Raju S; Jayaraj A
J Vasc Surg Venous Lymphat Disord; 2023 Jan; 11(1):82-90.e2. PubMed ID: 35872144
[TBL] [Abstract][Full Text] [Related]
4. Effect of body mass index on initial presentation and outcomes after stenting for quality of life-impairing chronic iliofemoral venous obstruction.
Jayaraj A; Powell T; Raju S
J Vasc Surg Venous Lymphat Disord; 2022 Mar; 10(2):325-333.e1. PubMed ID: 34358674
[TBL] [Abstract][Full Text] [Related]
5. Impact of degree of stenosis in May-Thurner syndrome on iliac vein stenting.
Jayaraj A; Buck W; Knight A; Johns B; Raju S
J Vasc Surg Venous Lymphat Disord; 2019 Mar; 7(2):195-202. PubMed ID: 30553783
[TBL] [Abstract][Full Text] [Related]
6. Technique of stent sizing in patients with symptomatic chronic iliofemoral venous obstruction-the case for intravascular ultrasound-determined inflow channel luminal area-based stenting and associated long-term outcomes.
Jayaraj A; Thaggard D; Lucas M
J Vasc Surg Venous Lymphat Disord; 2023 May; 11(3):634-641. PubMed ID: 36731654
[TBL] [Abstract][Full Text] [Related]
7. Long-term clinical outcomes and technical factors with the Wallstent for treatment of chronic iliofemoral venous obstruction.
Gagne PJ; Gagne N; Kucher T; Thompson M; Bentley D
J Vasc Surg Venous Lymphat Disord; 2019 Jan; 7(1):45-55. PubMed ID: 30558730
[TBL] [Abstract][Full Text] [Related]
8. Characteristics and outcomes of stent occlusion after iliocaval stenting.
Jayaraj A; Crim W; Knight A; Raju S
J Vasc Surg Venous Lymphat Disord; 2019 Jan; 7(1):56-64. PubMed ID: 30442577
[TBL] [Abstract][Full Text] [Related]
9. Outcomes and predictors of failure of iliac vein stenting after catheter-directed thrombolysis for acute iliofemoral thrombosis.
Avgerinos ED; Saadeddin Z; Abou Ali AN; Pandya Y; Hager E; Singh M; Al-Khoury G; Makaroun MS; Chaer RA
J Vasc Surg Venous Lymphat Disord; 2019 Mar; 7(2):153-161. PubMed ID: 30660580
[TBL] [Abstract][Full Text] [Related]
10. Utility of the 50% stenosis criterion for patients undergoing stenting for chronic iliofemoral venous obstruction.
Jayaraj A; Powell T; Raju S
J Vasc Surg Venous Lymphat Disord; 2021 Nov; 9(6):1408-1415. PubMed ID: 34098125
[TBL] [Abstract][Full Text] [Related]
11. Secondary interventions after iliac vein stenting for chronic proximal venous outflow obstruction.
Aboubakr A; Chait J; Lurie J; Schanzer HR; Marin ML; Faries PL; Ting W
J Vasc Surg Venous Lymphat Disord; 2019 Sep; 7(5):670-676. PubMed ID: 31068276
[TBL] [Abstract][Full Text] [Related]
12. Unexpected major role for venous stenting in deep reflux disease.
Raju S; Darcey R; Neglén P
J Vasc Surg; 2010 Feb; 51(2):401-8; discussion 408. PubMed ID: 20006920
[TBL] [Abstract][Full Text] [Related]
13. In-stent restenosis and stent compression following stenting for chronic iliofemoral venous obstruction.
Jayaraj A; Fuller R; Raju S; Stafford J
J Vasc Surg Venous Lymphat Disord; 2022 Jan; 10(1):42-51. PubMed ID: 34174500
[TBL] [Abstract][Full Text] [Related]
14. The beneficial role of complex decongestive therapy in patients with symptomatic chronic iliofemoral venous obstruction with phlebolymphedema.
Jayaraj A; Thaggard D
J Vasc Surg Venous Lymphat Disord; 2024 Jan; 12(1):101686. PubMed ID: 37714459
[TBL] [Abstract][Full Text] [Related]
15. Placement of closed-cell designed venous stents in a mixed cohort of patients with chronic venous outflow obstructions - short-term safety, patency, and clinical outcomes.
Lichtenberg M; Breuckmann F; Stahlhoff WF; Neglén P; Rick G
Vasa; 2018 Oct; 47(6):475-481. PubMed ID: 30175948
[TBL] [Abstract][Full Text] [Related]
16. One-Year Results of Iliocaval Stenting.
Tosenovsky P
Ann Vasc Surg; 2019 Aug; 59():208-216. PubMed ID: 30826434
[TBL] [Abstract][Full Text] [Related]
17. Effect of venous access site on postintervention stent thrombosis for nonthrombotic iliac vein stenting.
Chait J; Alsheekh A; Aurshina A; Haggerty J; Ostrozhynskyy Y; Rajaee S; Hingorani A; Ascher E
J Vasc Surg Venous Lymphat Disord; 2020 Jan; 8(1):84-88. PubMed ID: 31231060
[TBL] [Abstract][Full Text] [Related]
18. Pivotal Study of Endovenous Stent Placement for Symptomatic Iliofemoral Venous Obstruction.
Razavi MK; Black S; Gagne P; Chiacchierini R; Nicolini P; Marston W;
Circ Cardiovasc Interv; 2019 Dec; 12(12):e008268. PubMed ID: 31833414
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of stenting nonthrombotic iliac vein lesions in octogenarians and nonagenarians in an office setting.
Kibrik P; Eisenberg J; Alsheekh A; Rizvi SA; Aurshina A; Marks N; Hingorani A; Ascher E
Vascular; 2018 Feb; 26(1):70-74. PubMed ID: 28728480
[TBL] [Abstract][Full Text] [Related]
20. Randomized double-blinded study comparing medical treatment versus iliac vein stenting in chronic venous disease.
Rossi FH; Kambara AM; Izukawa NM; Rodrigues TO; Rossi CB; Sousa AG; Metzger PB; Thorpe PE
J Vasc Surg Venous Lymphat Disord; 2018 Mar; 6(2):183-191. PubMed ID: 29292114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
